NCT02171741 Dose Escalation Trial of BIBW 2992 Administration in Combination With Docetaxel in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02171728 Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02171715 BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02171702 Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT02171689 Metabolism and Pharmacokinetics of [14C]- BIBW 2992 MA2 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02171676 BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02171663 Dose Escalation Study of BIBW 2992 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02171637 Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02171624 Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate Status COMPLETED Phase PHASE1
NCT02171611 Bioavailability of Different Applications of Dabigatran in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02171598 Investigation of the Impact of Concomitant Use of Multiple Doses of Clopidogrel With Multiple Doses of Dabigatran Etexilate on the Pharmacokinetic and Pharmacodynamic Parameters in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02171585 Bioavailability of Dabigatran With or Without Clarithromycin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02171572 Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT02171559 Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02171546 Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers Status TERMINATED Phase PHASE1
NCT02171533 Relative Bioavailability of Single Oral Doses of Dabigatran Etexilate With or Without Oral Administration of Verapamil in Two Different Dosages in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02171520 Bioequivalence of Two Different Generations of Drug Product of Dabigatran Etexilate Following Oral Administration in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02171507 Relative Bioavailability of Dabigatran and Diclofenac After Dabigatran Etexilate and Diclofenac Single Dose Alone or Following Concomitant Multiple Oral Administrations in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT02171494 Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers Status COMPLETED Phase PHASE1